Chemed EBITDA Margin 2010-2024 | CHE

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Chemed (CHE) over the last 10 years. The current EBITDA margin for Chemed as of September 30, 2024 is .
Chemed EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $2.38B $0.43B 17.96%
2024-06-30 $2.34B $0.42B 18.02%
2024-03-31 $2.29B $0.40B 17.52%
2023-12-31 $2.27B $0.40B 17.75%
2023-09-30 $2.23B $0.37B 16.67%
2023-06-30 $2.19B $0.37B 16.69%
2023-03-31 $2.16B $0.39B 17.88%
2022-12-31 $2.14B $0.40B 18.88%
2022-09-30 $2.13B $0.42B 19.68%
2022-06-30 $2.14B $0.43B 20.07%
2022-03-31 $2.14B $0.41B 19.18%
2021-12-31 $2.14B $0.40B 18.79%
2021-09-30 $2.13B $0.45B 21.02%
2021-06-30 $2.12B $0.43B 20.28%
2021-03-31 $2.09B $0.45B 21.48%
2020-12-31 $2.08B $0.45B 21.50%
2020-09-30 $2.07B $0.38B 18.42%
2020-06-30 $2.02B $0.37B 18.21%
2020-03-31 $1.99B $0.34B 16.91%
2019-12-31 $1.94B $0.30B 15.68%
2019-09-30 $1.88B $0.29B 15.47%
2019-06-30 $1.84B $0.29B 15.51%
2019-03-31 $1.81B $0.28B 15.34%
2018-12-31 $1.78B $0.28B 15.87%
2018-09-30 $1.75B $0.27B 15.46%
2018-06-30 $1.73B $0.26B 15.24%
2018-03-31 $1.70B $0.17B 9.71%
2017-12-31 $1.67B $0.15B 9.00%
2017-09-30 $1.64B $0.15B 8.90%
2017-06-30 $1.62B $0.14B 8.35%
2017-03-31 $1.59B $0.21B 13.38%
2016-12-31 $1.58B $0.22B 13.71%
2016-09-30 $1.57B $0.21B 13.55%
2016-06-30 $1.57B $0.22B 14.06%
2016-03-31 $1.56B $0.23B 14.45%
2015-12-31 $1.54B $0.22B 14.25%
2015-09-30 $1.52B $0.22B 14.44%
2015-06-30 $1.50B $0.21B 14.04%
2015-03-31 $1.47B $0.21B 14.11%
2014-12-31 $1.46B $0.21B 14.16%
2014-09-30 $1.43B $0.20B 13.82%
2014-06-30 $1.41B $0.19B 13.35%
2014-03-31 $1.41B $0.17B 12.31%
2013-12-31 $1.41B $0.18B 12.45%
2013-09-30 $1.43B $0.18B 12.69%
2013-06-30 $1.45B $0.19B 13.06%
2013-03-31 $1.44B $0.20B 13.99%
2012-12-31 $1.43B $0.20B 13.71%
2012-09-30 $1.41B $0.20B 13.89%
2012-06-30 $1.40B $0.20B 14.31%
2012-03-31 $1.38B $0.20B 14.23%
2011-12-31 $1.36B $0.19B 14.17%
2011-09-30 $1.34B $0.18B 13.72%
2011-06-30 $1.32B $0.18B 13.56%
2011-03-31 $1.30B $0.18B 13.59%
2010-12-31 $1.28B $0.18B 14.06%
2010-09-30 $1.25B $0.17B 13.79%
2010-06-30 $1.22B $0.17B 13.64%
2010-03-31 $1.20B $0.16B 13.37%
2009-12-31 $1.19B $0.16B 13.53%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.593B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 0.00
Quest Diagnostics (DGX) United States $18.259B 18.51
DaVita (DVA) United States $13.572B 17.55
Encompass Health (EHC) United States $10.188B 24.02
Elanco Animal Health (ELAN) United States $6.605B 15.72
RadNet (RDNT) United States $6.073B 134.49
Option Care Health (OPCH) United States $3.936B 18.65
Amedisys (AMED) United States $2.969B 21.13
LifeStance Health (LFST) United States $2.832B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.254B 26.45
U.S Physical Therapy (USPH) United States $1.477B 38.82
Aveanna Healthcare Holdings (AVAH) United States $1.128B 0.00
Pennant (PNTG) United States $1.070B 43.25
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00